Features of the course of AA-amyloidosis in rheumatoid arthritis against the background of COVID-19 infection
- Authors: Voloshinova E.V.1, Nikitina N.M.1, Smirnova N.D.1, Egorova E.V.1
-
Affiliations:
- Saratov State Medical University named after V.I. Razumovsky
- Issue: Vol 13, No 2 (2021)
- Pages: 72-75
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273846
- DOI: https://doi.org/10.18565/nephrology.2021.2.72-75
- ID: 273846
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
Elena V. Voloshinova
Saratov State Medical University named after V.I. Razumovsky
Email: voloshinovaelena@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia
Natalya M. Nikitina
Saratov State Medical University named after V.I. Razumovsky
Email: nikina02@yandex.ru
Dr. Sci. (Med.), Professor at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia
Natalya D. Smirnova
Saratov State Medical University named after V.I. Razumovsky
Email: syrrax@yandex.ru
Resident at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia
Ekaterina V. Egorova
Saratov State Medical University named after V.I. Razumovsky
Email: kapustik@mail.ru
Postgraduate Student at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia
References
- Merlini G., Bellotti V., Molecular Mechanisms of Amyloidosis. N. Engl. J. Med. 2003; 349: 583-596. doi: 10.1056/NEJMra023144.
- Лысенко Л.В. (Козловская), Рамеев В.В., Моисеев С.В., и соавт. Клинические рекомендации по диагностике и лечению системного амилоидоза. Клин. фармакология и терапия, 2020;1:13-24. Doi: 10.32756/ 0869-5490-2020-1-13-24.
- Мухин Н.А. Клинические проблемы амилоидоза почек. Клин. мед. 1983; 61:7-12
- Ahlmen M., Ahlmen J., Svalander C., Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin. Rheumatol. 1987; 6: 27-38. doi: 10.1007/BF02200997.
- Чеботарева Н.В., Гуляев С.В., Андросова Т.В. и соавт. Хроническая болезнь почек у больных ревматоидным артритом: частота, факторы риска, варианты поражения почек. Терапевтический архив. 2019;91(5):129-133.doi: 10.26442/00403660.2019.05.000255
- Муравьев Ю.В., Раденска-Лоповок С.Г., Алексеева А.В., с соавт. Необычное течение АА-амилоидоза у больной ревматоидным артритом. Научно- практическая ревматология. 2009;2:73-75
- Козловская Л.В., Варшавский В.А., Чегаева Т.В. и соавт. Амилоидоз: современный взгляд на проблему. Практическая нефрология. 1998;2:16-23
- Smolen J.S., Aletaha D., Bijlsma J.W., et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010; 69(4): 631-637. doi: 10.1136/ard.2009.123919.
- Kuroda T., Tanabe N., Kobayashi D., et al. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in reactive amyloidosis associated with rheumatoid arthritis // Rheumatol. Int. 2012;32(10):3155-3162. doi: 10.1007/s00296-011-2148-8.
- Муркамилов И.Т., Айтбаев К.А., Кудайбергенова И.О., Фомин В.В., Юсупов Ф.А. Ревматоидный артрит и поражения почек: современный взгляд на проблему. The scientific heritage. 2021;58:29-37. doi: 10.24412/9215-0365-2021-58-2-29-37
- Fernández-Nebro A., Tomero E., OrtizSantamaria V., et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am. J. Med. 2005;118(5):552-556. doi: 10.1016/j.amjmed.2005.01.028.
- Gottenberg J.E., Merle-Vincent F., Bentaberry F., et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy // Arthritis Rheum. 2003;48(7):2019-2024. doi: 10.1002/art.11163.
- Fiter J., Nolla J.M., Gomez Vaquero C., Valverde J. Treatment of amyloidosis secondary to rheumatoid arthritis with methotrexate. Med. Clin. (Barc). 2000;114(11):439. doi: 10.1016/s0025-7753(00)71323-6.
- Trefler J., Matyska-Piekarska E., Wagner T., KŁacki J. Amyloidosis-life threatening complication in rheumatoid arthritis patients. 2007;60(9-10): 457-461.
Supplementary files
